Verona starts cough trial
This article was originally published in Scrip
Executive Summary
Verona Pharma, the chronic respiratory disease-focused biotech company, has started its first clinical trial of VRP700 to treat chronic cough, a condition for which there is no truly safe and effective treatment for cough since currently available treatments are either morphine-based, or derivatives of morphine.